You see a filtered list - Keywords: Tacke-Selection
[10]C. Baeck, A. Wehr, K. R. Karlmark, F. Heymann, M. Vucur, N. Gassler, S. Huss, S. Klussmann, D. Eulberg, T. Luedde, C. Trautwein, F. Tacke,
"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury", Gut, vol. 61, no. 3, pp. 416–426. [bibtex] [doi]
[9]F. Heymann, J. Peusquens, I. Ludwig‐Portugall, M. Kohlhepp, C. Ergen, P. Niemietz, C. Martin, N. van Rooijen, J. C. Ochando, G. J. Randolph, T. Luedde, F. Ginhoux, C. Kurts, C. Trautwein, F. Tacke,
"Liver inflammation abrogates immunological tolerance induced by Kupffer cells", Hepatology, vol. 62, no. 1, pp. 279–291. [bibtex] [doi]
[8]F. Heymann, F. Tacke,
"Immunology in the liver — from homeostasis to disease", Nat. Rev. Gastroenterol. Hepatol., vol. 13, no. 2, pp. 88–110. [bibtex] [doi]
[7]O. Krenkel, J. Hundertmark, A. T. Abdallah, M. Kohlhepp, T. Puengel, T. Roth, D. P. P. Branco, J. C. Mossanen, T. Luedde, C. Trautwein, I. G. Costa, F. Tacke,
"Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis", Gut, vol. 69, no. 3, pp. 551–563. [bibtex] [doi]
[6]O. Krenkel, T. Puengel, O. Govaere, A. T. Abdallah, J. C. Mossanen, M. Kohlhepp, A. Liepelt, E. Lefebvre, T. Luedde, C. Hellerbrand, R. Weiskirchen, T. Longerich, I. G. Costa, Q. M. Anstee, C. Trautwein, F. Tacke,
"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis", Hepatology, vol. 67, no. 4, pp. 1270–1283. [bibtex] [doi]
[5]O. Krenkel, F. Tacke,
"Liver macrophages in tissue homeostasis and disease", Nat. Rev. Immunol., vol. 17, no. 5, pp. 306–321. [bibtex] [doi]
[4]S. Lefere, T. Püngel, J. Hundertmark, C. Penners, A. K. Frank, A. Guillot, K. de Muynck, F. Heymann, V. Adarbes, E. Defrêne, C. Estivalet, A. Geerts, L. Devisscher, G. Wettstein, F. Tacke,
"Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages", J. Hepatol., vol. 73, no. 4, pp. 757–770. [bibtex] [doi]
[3]J. C. Mossanen, M. Kohlhepp, A. Wehr, O. Krenkel, A. Liepelt, A. A. Roeth, D. Möckel, F. Heymann, T. Lammers, N. Gassler, J. Hermann, J. Jankowski, U. P. Neumann, T. Luedde, C. Trautwein, F. Tacke,
"CXCR6 inhibits hepatocarcinogenesis by promoting natural killer T- and CD4+ T-cell-dependent control of senescence", Gastroenterology, vol. 156, no. 6, pp. 1877–1889.e4. [bibtex] [doi]
[2]F. Tacke, D. Alvarez, T. J. Kaplan, C. Jakubzick, R. Spanbroek, J. Llodra, A. Garin, J. Liu, M. Mack, N. van Rooijen, S. A. Lira, A. J. Habenicht, G. J. Randolph,
"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques", J. Clin. Invest., vol. 117, no. 1, pp. 185–194. [bibtex] [doi]
[1]F. Tacke, F. Ginhoux, C. Jakubzick, N. van Rooijen, M. Merad, G. J. Randolph,
"Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery", J. Exp. Med., vol. 203, no. 3, pp. 583–597. [bibtex] [doi]